REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
12/06/2025
Back to search
Official data from USPTO
MICRODOSE THERAPY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MICRODOSE THERAPY
ST13
US500000086919468Class
41
Filing
86919468
Registration
5094273
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
12/07/2025
Trademark type
Word
Nice classes
41
Filing date
02/25/2016
Registration date
12/06/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/08/2023
Last transaction
12/07/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
11/01/1991
First use in commerce
11/01/1991
Drawing code
4
Owner type
16
Owner location
Apache Junction, AZ
Examiner
TIERNEY, MARGERY
Law office
M20
Current location
TMO LAW OFFICE 111
Holders and representatives
Holders
HFC Limited LLC
Representatives
Clint D. Cadwallader MCGRATH NORTH MULLIN & KRATZ, PC LLO
Technical classification
Nice Classes
Class 41
Vienna Codes
No Vienna codes available.
Goods and services
Class 41
Medical education servicessupervised training regarding self-administration of steroid medication for reducing inflammation and pain caused by arthritis
Publications
History of USPTO decisions and trademark events.
25 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/08/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/08/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/08/2023
E815
TEAS SECTION 8 & 15 RECEIVED
12/06/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/06/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
12/06/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/20/2016
PUBO
PUBLISHED FOR OPPOSITION
09/20/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/31/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/08/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
08/08/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/08/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
08/08/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/08/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/30/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/29/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/29/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/20/2016
GNRT
NON-FINAL ACTION E-MAILED
06/20/2016
CNRT
NON-FINAL ACTION WRITTEN
06/20/2016
DOCK
ASSIGNED TO EXAMINER
06/09/2016
MPMK
NOTICE OF PSEUDO MARK E-MAILED
03/02/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/01/2016
NWAP
NEW APPLICATION ENTERED
02/29/2016
Continuous trademark protection
Get notified about every new filing that threatens MICRODOSE THERAPY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.